
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
17β-Estradiol counteracts pathological microtubule remodeling to enhance right ventricular function in preclinical models.
Journal: The Journal of clinical investigation
Published: May 07, 2026
Incident Atrial Fibrillation and Flutter in Patients With Pulmonary Arterial Hypertension: Influence of Right Ventricular Dilatation and Reduced Right Atrial Function.
Journal: Journal of the American Heart Association
Published: April 20, 2026
Lactobacillus Is Associated With Disease in Pulmonary Arterial Hypertension: A Prospective Cohort Study.
Journal: Comprehensive Physiology
Published: February 21, 2026
Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated Hepatopathy.
Journal: JACC. Basic to translational science
Published: February 19, 2026
Highlights of the 2026 Pulmonary Vascular Research Institute Conference: Celebrating 20 Years of Progress and Innovation.
Journal: Pulmonary circulation
Published: February 03, 2026
The Importance of Liver-Lung Communication in Pulmonary Vascular Diseases.
Journal: Comprehensive Physiology
Published: December 17, 2025
Global Resource Disparities Between Pulmonary Hypertension Centers: Results From the International Survey by the PVRI IDDI Access to Care Workstream.
Journal: Pulmonary circulation
Published: October 30, 2025
Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated Hepatopathy.
Journal: bioRxiv : the preprint server for biology
Published: September 15, 2025
Interstitial Macrophages Drive Pulmonary Arteriole Medial Fibrosis in PAH.
Journal: Circulation research
Published: June 19, 2025
Lactobacillus Restructures the Micro/Mycobiome to Combat Inflammation-Mediated Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
Journal: Circulation. Heart failure
Published: May 16, 2025
Editorial: Exploring the role of epigenetic modifications in pulmonary vascular disease pathogenesis.
Journal: Frontiers in medicine
Published: April 25, 2025
Proteomic and Metabolomic Profiling Nominates Druggable Targets and Biomarkers for Pulmonary Arterial Hypertension-Associated Myopathy and Exercise Intolerance.
Journal: bioRxiv : the preprint server for biology
Published: April 08, 2025
Last Updated: 09/26/2026